# Newbiotics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/newbiotics

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Total disclosed funding: $11M
- Latest round: Series C (Jul 30, 2001)
- Investors on record: 7

## About

Newbiotics inc. is based in US and operates as a pharmaceutical company engaged in the development of breakthrough drugs for the treatment of cancer and infectious disease.

## Funding rounds

- Series C, Jul 30, 2001, $11M — BioVeda Capital, Mesa Verde Venture Partners, GeneChem, Life Science Venture Partners, Cheng Xin Venture Capital Group, FAT Capital Management, HMCH Ventures

## Investors

- BioVeda Capital (https://capitalatlas.ai/funds/bioveda-capital) — Series C
- Mesa Verde Venture Partners (https://capitalatlas.ai/funds/mesa-verde-venture-partners) — Series C
- GeneChem (https://capitalatlas.ai/funds/genechem) — Series C
- Life Science Venture Partners — Series C
- Cheng Xin Venture Capital Group (https://capitalatlas.ai/funds/cheng-xin-venture-capital-group) — Series C
- FAT Capital Management (https://capitalatlas.ai/funds/fat-capital-management) — Series C
- HMCH Ventures — Series C